Oral 1: Dronabinol Increases Pain Threshold in Non-Cardiac Chest Pain: A Double Blind Placebo Controlled Trial
Oral Presentation: Monday, Oct 20, 8:00 AM – 8:12 AM
Author Insight from Ron Schey, MD., FACG, Temple University
What’s new here and important for clinicians?
This is the first study to demonstrate that Dronabinol (cannabinoid drug) is effective in non-cardiac chest pain.
What do patients need to know?
That there is hope for many of the patients who do not respond to current treatment, and that a 4 week treatment DID not demonstrate any major side effects.
Ron Schey, M.D.,FACG
Temple University Physicians/Section of Gastroenterology
Media Interview Requests:
To arrange an interview with any ACG experts or abstract authors please contact Jacqueline Gaulin of ACG via email email@example.com or by phone at 301-263-9000.